| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |